Literature DB >> 12209360

Evidence for a locus (IDDM16) in the immunoglobulin heavy chain region on chromosome 14q32.3 producing susceptibility to type 1 diabetes.

L L Field1, Z Larsen, F Pociot, J Nerup, R Tobias, V Bonnevie-Nielsen.   

Abstract

Type 1 diabetes results from autoimmune destruction of pancreatic islet beta-cells, possibly initiated or exacerbated by viral infections. Recent studies have demonstrated that antibodies towards enterovirus and autoantibodies towards islet cell components develop in the long preclinical phase of type 1 diabetes. We therefore hypothesised that susceptibility to type 1 diabetes could be influenced by genetic factors controlling production of antiviral antibodies or autoantibodies or both. To search for evidence of linkage or association (linkage disequilibrium) between type 1 diabetes and the immunoglobulin heavy chain (IGH) region, 351 North American and British families with > or =2 diabetic children were genotyped for IGH region microsatellites. Using affected sibpair analysis, significant evidence for linkage was obtained for three markers close to the IGH gene cluster (P values 0.004, 0.002, 0.002). No evidence was found for association using family-based methods. To attempt to confirm these findings, a smaller dataset (241 families, 138 with > or =2 diabetic children) from Denmark, a more genetically-homogeneous population, was genotyped for one marker only. These families showed no linkage, but significant evidence for association (P = 0.019). This study suggests that a locus (assigned the symbol IDDM16) in the IGH region, possibly an IGH gene, influences susceptibility to type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209360     DOI: 10.1038/sj.gene.6363857

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  5 in total

1.  Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes.

Authors:  Dongmei Han; Carlos A Leyva; Della Matheson; Davide Mineo; Shari Messinger; Bonnie B Blomberg; Ana Hernandez; Luigi F Meneghini; Gloria Allende; Jay S Skyler; Rodolfo Alejandro; Alberto Pugliese; Norma S Kenyon
Journal:  Clin Immunol       Date:  2011-02-24       Impact factor: 3.969

2.  Complete haplotype sequence of the human immunoglobulin heavy-chain variable, diversity, and joining genes and characterization of allelic and copy-number variation.

Authors:  Corey T Watson; Karyn M Steinberg; John Huddleston; Rene L Warren; Maika Malig; Jacqueline Schein; A Jeremy Willsey; Jeffrey B Joy; Jamie K Scott; Tina A Graves; Richard K Wilson; Robert A Holt; Evan E Eichler; Felix Breden
Journal:  Am J Hum Genet       Date:  2013-03-28       Impact factor: 11.025

Review 3.  Risk factors and primary prevention trials for type 1 diabetes.

Authors:  Yan-Ling Wu; Yan-Ping Ding; Jian Gao; Yoshimasa Tanaka; Wen Zhang
Journal:  Int J Biol Sci       Date:  2013-07-18       Impact factor: 6.580

Review 4.  Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response.

Authors:  Matthew Clark; Charles J Kroger; Roland M Tisch
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

Review 5.  Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes.

Authors:  Charles J Kroger; Matthew Clark; Qi Ke; Roland M Tisch
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.